These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 66177

  • 1. Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy.
    Jaffiol C, Baldet L, Robin M, Papachristou C, Lapinski H, Mirouze J.
    Horm Metab Res; 1977 Jan; 9(1):73-81. PubMed ID: 66177
    [Abstract] [Full Text] [Related]

  • 2. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
    Sorger D, Schenk S, Schneider G.
    Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
    [Abstract] [Full Text] [Related]

  • 3. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N, Yabu Y, Miki T, Morimoto S, Kumahara Y, Mori H, Iwatani Y, Nishi K, Nakatani K, Miyai K.
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [Abstract] [Full Text] [Related]

  • 4. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
    Gedik O, Ozdemir T, Akalin S.
    Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765
    [Abstract] [Full Text] [Related]

  • 5. Relationship between serum free thyroxine, total thyroxine and thyroxine-binding globulin concentrations in patients with Graves' disease.
    Bannai C, Yamashita K, Kugai N, Koide Y, Akisada M.
    Horm Metab Res; 1985 Dec; 17(12):671-3. PubMed ID: 3936763
    [Abstract] [Full Text] [Related]

  • 6. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ, Ladenson PW.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [Abstract] [Full Text] [Related]

  • 7. Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinoma.
    Rajatanavin R, Liberman C, Lawrence GD, D'Arcangues CM, Young RA, Emerson CH.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):17-21. PubMed ID: 2987291
    [Abstract] [Full Text] [Related]

  • 8. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M, Moka D, Reinholz U, Schmidt M, Schomäcker K, Schicha H, Wellner U.
    Nuklearmedizin; 2007 Jul; 46(3):77-84. PubMed ID: 17549318
    [Abstract] [Full Text] [Related]

  • 9. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR.
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [Abstract] [Full Text] [Related]

  • 10. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L, Huot C, Lambert R, Deal C, Collu R, Van Vliet G.
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [Abstract] [Full Text] [Related]

  • 11. Graves' disease associated with familial deficiency of thyroxine-binding globulin.
    Horwitz DL, Refetoff S.
    J Clin Endocrinol Metab; 1977 Feb; 44(2):242-7. PubMed ID: 402376
    [Abstract] [Full Text] [Related]

  • 12. Thyroxine-binding globulin and thyroid hormones after resection of hepatocellular carcinoma.
    Nagasue N, Ohmori H, Hashimoto N, Tachibana M, Kubota H, Uchida M, Yu L.
    Am J Gastroenterol; 1997 Jul; 92(7):1187-9. PubMed ID: 9219796
    [Abstract] [Full Text] [Related]

  • 13. Changes in serum thyrotropin (TSH) in man during halofenate administration.
    Davis PJ, Davis FB, Utiger RD, Kulaga SF.
    J Clin Endocrinol Metab; 1976 Oct; 43(4):873-81. PubMed ID: 824301
    [Abstract] [Full Text] [Related]

  • 14. Radioimmunoassay of thyroxine in saliva.
    Putz Z, Vanuga A, Velemínský J.
    Exp Clin Endocrinol; 1985 Apr; 85(2):199-203. PubMed ID: 3926523
    [Abstract] [Full Text] [Related]

  • 15. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ, Lee BW, Kim JY, Jung JH, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E, Gardini E, Minelli R, Bianconi L, Salvi M, Gavaruzzi G, Braverman LE.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [Abstract] [Full Text] [Related]

  • 17. Thyroxine-binding globulin, triiodothyronine, thyroxine and thyrotropin in newborn infants and children.
    Stubbe P, Gatz J, Heidemann P, Mühlen A, Hesch R.
    Horm Metab Res; 1978 Jan; 10(1):58-61. PubMed ID: 415959
    [Abstract] [Full Text] [Related]

  • 18. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).
    Chopra IJ, Williams DE, Orgiazzi J, Solomon DH.
    J Clin Endocrinol Metab; 1975 Nov; 41(5):911-20. PubMed ID: 1242390
    [Abstract] [Full Text] [Related]

  • 19. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
    Burch HB, Solomon BL, Cooper DS, Ferguson P, Walpert N, Howard R.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3016-21. PubMed ID: 11443161
    [Abstract] [Full Text] [Related]

  • 20. Binding activities of thyroxine binding globulin versus thyroxine binding prealbumin in rat sera: differential modulation by thyroid hormone ligands, oleic acid and pharmacological drugs.
    Savu L, Vranckx R, Maya M, Nunez EA.
    Biochem Biophys Res Commun; 1989 Mar 31; 159(3):919-26. PubMed ID: 2495002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.